Illumina on Tuesday said its board has approved plans to spin off Grail, the early cancer screening company it founded, spun off, and then reacquired for $8 billion over the objections of ...

In its announcement, the EC ordered Illumina to “submit a concrete divestment plan for the disposal of Grail,” which will then be reviewed for approval. In the meantime, Illumina will remain ...

before first securing EU regulatory approval. BRUSSELS (Reuters) -U.S. gene sequencing company Illumina's plan to divest cancer diagnostic test maker Grail received the green light from EU antitrust ...

Illumina's attempt to prevent the ... companies must wait for our approval before a transaction can go ahead". Under EU law, the Commission can impose fines up to 10% of aggregate turnover on ...